Johnson & Johnson Price to Sales Ratio 2006-2019 | JNJ
Historical PS ratio values for Johnson & Johnson (JNJ) over the last 10 years. The current P/S ratio for Johnson & Johnson as of June 24, 2019 is .
| Johnson & Johnson P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2019-06-24 |
143.06 |
|
4.77 |
| 2019-03-31 |
139.79 |
$30.01 |
4.66 |
| 2018-12-31 |
128.20 |
$29.91 |
4.29 |
| 2018-09-30 |
136.39 |
$29.79 |
4.58 |
| 2018-06-30 |
118.99 |
$29.51 |
4.03 |
| 2018-03-31 |
124.74 |
$28.73 |
4.34 |
| 2017-12-31 |
135.14 |
$27.86 |
4.85 |
| 2017-09-30 |
124.99 |
$26.99 |
4.63 |
| 2017-06-30 |
126.38 |
$26.21 |
4.82 |
| 2017-03-31 |
118.20 |
$25.95 |
4.55 |
| 2016-12-31 |
108.63 |
$25.74 |
4.22 |
| 2016-09-30 |
110.62 |
$25.58 |
4.32 |
| 2016-06-30 |
112.83 |
$25.27 |
4.46 |
| 2016-03-31 |
99.94 |
$24.98 |
4.00 |
| 2015-12-31 |
94.20 |
$24.90 |
3.78 |
| 2015-09-30 |
84.98 |
$24.94 |
3.41 |
| 2015-06-30 |
88.03 |
$25.29 |
3.48 |
| 2015-03-31 |
90.21 |
$25.75 |
3.50 |
| 2014-12-31 |
93.12 |
$25.91 |
3.59 |
| 2014-09-30 |
94.31 |
$25.91 |
3.64 |
| 2014-06-30 |
91.94 |
$25.56 |
3.60 |
| 2014-03-31 |
85.73 |
$24.96 |
3.43 |
| 2013-12-31 |
79.36 |
$24.78 |
3.20 |
| 2013-09-30 |
74.60 |
$24.65 |
3.03 |
| 2013-06-30 |
73.34 |
$24.60 |
2.98 |
| 2013-03-31 |
69.12 |
$24.30 |
2.84 |
| 2012-12-31 |
58.96 |
$24.00 |
2.46 |
| 2012-09-30 |
57.45 |
$23.61 |
2.43 |
| 2012-06-30 |
55.82 |
$23.32 |
2.39 |
| 2012-03-31 |
53.98 |
$23.40 |
2.31 |
| 2011-12-31 |
53.20 |
$23.42 |
2.27 |
| 2011-09-30 |
51.19 |
$23.17 |
2.21 |
| 2011-06-30 |
52.99 |
$22.79 |
2.33 |
| 2011-03-31 |
46.79 |
$22.30 |
2.10 |
| 2010-12-31 |
48.41 |
$22.06 |
2.19 |
| 2010-09-30 |
48.08 |
$22.38 |
2.15 |
| 2010-06-30 |
45.40 |
$22.40 |
2.03 |
| 2010-03-31 |
49.67 |
$22.40 |
2.22 |
| 2009-12-31 |
48.69 |
$22.20 |
2.19 |
| 2009-09-30 |
45.67 |
$21.62 |
2.11 |
| 2009-06-30 |
42.26 |
$21.84 |
1.94 |
| 2009-03-31 |
38.79 |
$22.15 |
1.75 |
| 2008-12-31 |
43.76 |
$22.41 |
1.95 |
| 2008-09-30 |
50.27 |
$22.54 |
2.23 |
| 2008-06-30 |
46.39 |
$22.05 |
2.10 |
| 2008-03-31 |
46.44 |
$21.45 |
2.17 |
| 2007-12-31 |
47.44 |
$20.94 |
2.27 |
| 2007-09-30 |
46.44 |
$20.08 |
2.31 |
| 2007-06-30 |
43.27 |
$19.45 |
2.22 |
| 2007-03-31 |
42.04 |
$18.76 |
2.24 |
| 2006-12-31 |
45.79 |
$17.96 |
2.55 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$377.257B |
$81.581B |
|
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
|
